CHEMICAL AND KINETIC STUDY OF THE LIPOPROTEINS IN ABETALIPOPROTEINAEMIC PLASMA.SHEPHERD J; CASLAKE M; FARISH E et al.1978; J. CLIN. PATHOL.; G.B.; DA. 1978; VOL. 31; NO 4; PP. 382-387; BIBL. 28 REF.Article

THE COMPOSITION OF LOW-DENSITY LIPOPROTEIN AND VERY-LOW-DENSITY LIPOPROTEIN SUBFRACTIONS IN PRIMARY HYPOTHYROIDISM AND THE EFFECT OF HORMONE-REPLACEMENT THERAPYBALLANTYNE FC; EPENETOS AA; CASLAKE M et al.1979; CLIN. SCI.; GBR; DA. 1979; VOL. 57; NO 1; PP. 83-88; BIBL. 21 REF.Article

A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipidFORBES, S; GODSLAND, I. F; BEDFORD, D et al.Diabetologia (Berlin). 2013, Vol 56, Num 9, pp 2021-2033, issn 0012-186X, 13 p.Article

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjectsMALMSTRÖM, R; PACKARD, C. J; CASLAKE, M et al.Diabetes (New York, NY). 1998, Vol 47, Num 5, pp 779-787, issn 0012-1797Article

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDMMALMSTRÖM, R; PACKARD, C. J; CASLAKE, M et al.Diabetologia (Berlin). 1997, Vol 40, Num 4, pp 454-462, issn 0012-186XArticle

Metabolic basis of hypotriglyceridemic effects of insulin in normal menMALMSTRÖM, R; PACKARD, C. J; WATSON, T. D. G et al.Arteriosclerosis, thrombosis, and vascular biology. 1997, Vol 17, Num 7, pp 1454-1464, issn 1079-5642Article

In vivo and in vitro studies of the role of HDL in platelet activation in normotensive and hypertensive subjectsGRAHAM, D; SIMPSON, H. D; DOMINICZAK, A. F et al.Journal of human hypertension. 1995, Vol 9, Num 9, pp 753-758, issn 0950-9240Article

The Xbal polymorphism of the apolipoprotein B gene influences the degradation of low density lipoprotein in vitroSERIES, J; CAMERON, I; CASLAKE, M et al.Biochimica et biophysica acta. 1989, Vol 1003, Num 2, pp 183-188, issn 0006-3002Article

Non-high-density lipoprotein cholesterol as a risk factor: addressing risk associated with apolipoprotein B-containing lipoproteinsCHAPMAN, M. J; CASLAKE, M.European heart journal supplements. 2004, Vol 6, Num A, pp A43-A48, issn 1520-765XConference Paper

Low density lipoprotein particle size and risk factors of insulin resistance syndromeFRIEDLANDER, Y; KIDRON, M; CASLAKE, M et al.Atherosclerosis. 2000, Vol 148, Num 1, pp 141-149, issn 0021-9150Article

Sodium-lithium countertransport, sodium-hydrogen exchange and membrane microviscosity in patients with hyperlipidaemiaMACLEOD, M. J; LEE, W. K; DEVLIN, A. M et al.Clinical science (1979). 1997, Vol 92, Num 3, pp 237-246, issn 0143-5221Article

Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjectsMALMSTRÖM, R; PACKARD, C. J; CASLAKE, M et al.Atherosclerosis. 1999, Vol 146, Num 2, pp 381-390, issn 0021-9150Article

Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopauseGRIFFIN, B; FARISH, E; WALSH, D et al.Clinical endocrinology (Oxford. Print). 1993, Vol 39, Num 4, pp 463-468, issn 0300-0664Article

Central AfricaLAWLESS, S. R; CASLAKE, M; YOUNG, E. W et al.1978, 192 p.Book

Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?LOCKINGTON, D; MACDONALD, Eca; STEWART, P et al.Eye (London. 1987). 2012, Vol 26, Num 5, pp 734-741, issn 0950-222X, 8 p.Article

Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IXGEBERHIWOT, T; ALGER, S; MCKIERNAN, P et al.Journal of inherited metabolic disease. 2007, Vol 30, Num 3, issn 0141-8955, 406Article

The role of small, dense low density lipoprotein (LDL) : a new lookPACKARD, C; CASLAKE, M; SHEPHERD, J et al.International journal of cardiology. 2000, Vol 74, pp S17-S22, issn 0167-5273, SUP1Article

Atherogenic lipoprotein phenotype in Type 2 diabetes : Reversal with micronised fenofibrateFEHER, M. D; CASLAKE, M; FOXTON, J et al.Diabetes/metabolism research and reviews (Print). 1999, Vol 15, Num 6, pp 395-399, issn 1520-7552Article

Low-density lipoprotein metabolism following renal transplantationTSAKIRIS, D; CASLAKE, M. J; BRIGGS, J. D et al.Transplantation. 1985, Vol 39, Num 4, pp 458-460, issn 0041-1337Article

Energy replacement attenuates the effects of prior moderate exercise on postprandial metabolism in overweight/obese menBURTON, F. L; MALKOVA, D; CASLAKE, M. J et al.International journal of obesity. 2008, Vol 32, Num 3, pp 481-489, issn 0307-0565, 9 p.Article

Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemiasDUVILLARD, L; CASLAKE, M. J; PETIT, J. M et al.Atherosclerosis. 2008, Vol 199, Num 1, pp 27-33, issn 0021-9150, 7 p.Article

Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjectsWATSON, T. D. G; CASLAKE, M. J; FREEMAN, D. J et al.Arteriosclerosis and thrombosis. 1994, Vol 14, Num 6, pp 902-910, issn 1049-8834Article

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions : relative contribution of small, dense LDL to coronary heart disease riskGRIFFIN, B. A; FREEMAN, D. J; TAIT, G. W et al.Atherosclerosis. 1994, Vol 106, Num 2, pp 241-253, issn 0021-9150Article

Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemiaCASLAKE, M. J; PACKARD, C. J; GAW, A et al.Arteriosclerosis and thrombosis. 1993, Vol 13, Num 5, pp 702-711, issn 1049-8834Article

Plasma triglyceride and low density lipoprotein metabolismCASLAKE, M. J; PACKARD, C. J; SERIES, J. J et al.European journal of clinical investigation. 1992, Vol 22, Num 2, pp 96-104, issn 0014-2972Article